FDA Inspection
Amgen Inc.Amgen Inc. – FDA Inspection, Nov 6, 2025
Record Details
This FDA Inspection record concerns Amgen Inc., with an inspection on November 6, 2025, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · fa1bdcd1-cd95-435e-a357-cacef4563079
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1293010
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Amgen Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 30, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Amgen Inc.
- FDA Inspection 1234412 - 2024-07-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.